Results 1 to 10 of about 522 (134)

Rhinitis Medicamentosa

open access: yesUgeskrift for Læger
Sales of over-the-counter decongestant nasal sprays in Denmark from 2011 to 2023 have doubled. This article highlights the potential risks associated with prolonged use of decongestant nasal sprays, such as rhinitis medicamentosa. We conclude that there is an urgent need for increased patient education on proper use and possible side effects of over ...
Wahid NWB, Shermetaro C.
europepmc   +6 more sources

Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. [PDF]

open access: yesJ Otolaryngol Head Neck Surg, 2019
Background Rhinitis medicamentosa is a non-allergic form of rhinitis that is typically caused by prolonged use of topical nasal decongestants. This condition commonly affects young adults and treatment is not trivial. We aimed to survey Canadian Otolaryngologists to determine practice patterns and their opinions regarding this under-studied condition ...
Fowler J, Chin CJ, Massoud E.
europepmc   +6 more sources

Part II - imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? [PDF]

open access: yesFront Pharmacol
Rhinitis medicamentosa is the state of chronic congestion experienced from the prolonged or excessive use of nasal vasoconstrictors, typically used in the treatment of nasal congestion.
Stinson RJ, Sadofsky LR.
europepmc   +2 more sources

Rhinitis medicamentosa – preventable disease

open access: yesMedical Council, 2019
Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made.
A. I. Kryukov   +4 more
openaire   +4 more sources

Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion. [PDF]

open access: yesJ Asthma Allergy, 2022
RS Kumar,1 Manish Kumar Jain,2 Jitendra Singh Kushwaha,3 Santosh Patil,4 Vasanti Patil,5 Soumya Ghatak,6 Jayesh Sanmukhani,7 Ravindra Mittal7 1Department of Pulmonary Medicine, Government Medical College & Government General Hospital, Srikakulam, India ...
Kumar RS   +7 more
europepmc   +2 more sources

Pathological conditions associated with rhinitis medicamentosa [PDF]

open access: yesSrpski arhiv za celokupno lekarstvo, 2004
Rhinitis medicamentosa (nose-drop-nose") is a term used for pathological condition of the nasal mucous membrane that results from long-term abuse with intranasal vasoconstrictors. The aim of this work was to examine what lead the patients with nosedropnose rhinitis to the initial usage of intranasal vasoactive drugs, in this prospective study, 92 ...
Milošević Dušanka   +3 more
openaire   +2 more sources

Part 1 - imidazolines and the changing face of nasal decongestants. [PDF]

open access: yesFront Pharmacol
Imidazolines are sympathomimetic drugs used to treat a range of conditions including nasal congestion, ocular disorders, and hypertension. Imidazolines were discovered over 150 years ago.
Stinson RJ, Sadofsky LR.
europepmc   +2 more sources

Pharmacovigilance analysis of drug-induced hypertrophic rhinitis using FAERS data. [PDF]

open access: yesSci Rep
Our study aims to evaluate the risk of drug-induced hypertrophic rhinitis and analyze its epidemiological characteristics utilizing real-world data.
He Y, Yan X, Chen L, Lin Z.
europepmc   +2 more sources

ADVERSE EFFECTS OF NASAL DECONGESTANTS (REVIEW OF LITERATURE)

open access: yesНеонатологія, хірургія та перинатальна медицина, 2022
Nasal decongestants are ones of the most popular and widespread medicines due to high frequency of respiratory infections. But on the other hand they are characterized by significant abuse potential for users seeking such effects as euphoria ...
C. Левицька
doaj   +1 more source

Home - About - Disclaimer - Privacy